Three insiders buy Bambusa Therapeutics, Inc. shares, $58.6M in total
Open-market purchases on Nov 2, led by RA Capital Management, L.P. (director).
Three insiders at Bambusa Therapeutics, Inc. (BBTX) bought shares on the open market on Nov 2, a combined $58.6 million, according to Form 4 filings with the SEC.
By size, RA Capital Management, L.P., a director, leads with $46.6 million. Three or more insiders buying within 14 days is what Insider Stock Trader labels a cluster buy.
Every purchase was an open-market trade (transaction code P) of common stock, and none is marked as part of a 10b5-1 plan. The table below lists who bought, when, and at what price.
Details from the SEC filing:
| Insider | Role | Trade date | Shares | Avg. price | Value | Filing |
|---|---|---|---|---|---|---|
| Helmut Wolfgang Jeggle | Director | Nov 2 | 375,000 | $16.00 | $6,000,000 | App · SEC |
| Salvia Investment GmbH | 10% owner | Nov 2 | 375,000 | $16.00 | $6,000,000 | App · SEC |
| RA Capital Management, L.P. | Director | Nov 2 | 2,953,820 | $15.79 | $46,639,958 | App · SEC |
| Total | $58,639,958 | |||||
See more details on these BBTX insider trades
Each row of the table links to its Form 4 on SEC.gov.
Browse the latest insider buying · Read more BBTX insider trading news
Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.
